|
 |
|
Caregen, established in 2001, has committed to the R&D of growth factors and biomimetic
peptides which are produced by the transformed bacterial system and biomolecular
remodeling, respectively.
Caregen R&D Center has been in alliance with world-class research groups and companies
in Korea and overseas. We have established environments ranging from small-scale state-ofthe-
art laboratory to large commercial facilities.
|
 |
 |
Growth Factors
Caregen has committed to the R&D of growth factors, which are
produced by the transformed bacterial system. Developing high
quality growth factors and mass production skill are key factors of
Caregen technology.
Biomimetic Peptides
Caregen has been developing plenty of biomimetic peptides and
successfully commercialized to cosmeceuticals. Caregen is a
leading company in the field of developing biomimetic peptides for
cosmeceutical application.
Caregen is researching to expand its application to pharmaceuticals,
functional foods and therapeutics.
Enhancing Skin Penetration
Caregen has achieved double-layered capsulation technology as a
transdermal delivery system.
Every active ingredients are capsulated by double-layered
capsulation technology for better skin penetration ratio.
Stem Cell Research
Caregen has focused on the research of stem cell proliferation and
differentiation for cosmeceutical application.
|
 |
 |
|
| Caregen has developed biomimetic peptides since 2002 based on various and broad growth factor studies.
Caregen¡¯s commercialized peptides are excellent stimulators for anti-aging, anti-pigmentation, hair growth,
anti-inflammation, oral care, anti-microbial and lipolysis effects. |
Manufacturing Process of Biomimetic Peptides |
|
Comparative Advantages of Biomimetic Peptides
- Sustainable new biomimetic peptides development
- Competitive price based on mass production technology
- High efficacy and stability by double layered encapsulation technology
- High purity by sophisticated production facility and technical superiority |
|
Growth factors are proteins that bind to their own cellular receptors with the primary result
of activating cell proliferation and/or differentiation.
Not only as strong as mitogens, growth factors are regulating the expressions of
ECMs (Extra Cellular Matrix) like collagen, elastin and laminin etc. |
Manufacturing Process of Growth Factors |
 |
Superiority of Growth Factors
- Competitive price based on exclusive mass production technology
- High efficacy and stability by double layered encapsualation technology
- High purity by sophisticated production facility and technical superiority
|
 |
| Double-layered Encapsulation Technology |
| Caregen¡¯s Double-layered Encapsulation technology improves penetration efficiency of
active ingredients into skin. In addition, the molecules are protected from endogenous
proteases and peptidases due to Double-layered Encapsulation. |
 |
Advantages of Double-layered Encapsulation |
- High stability by double layered structure.
- High homogeneity: average diameter of particle is 140 nm and over 80% particles are
below 100 nm size.
- Efficient delivery of therapeutic cosmetic components into dermal layer. |
 |
| Active ingredients were effectively delivered into epidermal and dermal layer with
Double-layered Encapsulation technology. |
|
|
